Chest
Clinical InvestigationsCARDIOLOGYElectrocardiography to Define Clinical Status in Primary Pulmonary Hypertension and Pulmonary Arterial Hypertension Secondary to Collagen Vascular Disease
Section snippets
Materials and Methods
Sixty-one patients with PPH or pulmonary hypertension secondary to collagen vascular disease were identified retrospectively. The diagnosis of PPH or pulmonary hypertension was established according to standard criteria.9 Only patients who had undergone echocardiograms and cardiac catheterizations within 30 days of undergoing a 12-lead ECG were included in this study. Right-heart catheterizations were performed according to standard procedures. Cardiac outputs were calculated using the
Results
Of the 61 patients studied, 56 (92%) were women. Baseline patient information is presented in Table 1. Eight of 61 ECGs (13%) were read as being completely normal. There was a trend toward lower PVR and pulmonary artery pressure as well as toward a higher cardiac index in patients who had normal ECG findings; however, there were no significant differences in this limited patient sample.
Correlations of selected ECG parameters with hemodynamic, echocardiographic, and exercise capacity are shown
Discussion
An elevated right atrial (RA) pressure is an ominous finding in patients with PAH and is predictive of mortality.101112 A markedly elevated RA pressure, however, occurs late in the course of the disease when there is marked functional impairment. Ideally, ECG parameters would be both sensitive and specific in identifying patients early in the course of the disease when symptoms are mild. It is possible that therapy would be more efficacious if instituted early in the course of the disease
References (14)
Medical treatment of primary pulmonary hypertension: a bridge to transplantation?
Am J Cardiol
(1995)- et al.
The ECG in pulmonary embolism: predictive value of negative T waves in precordial leads; 80 case reports
Chest
(1997) - et al.
Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension
Am J Cardiol
(1994) - et al.
Prognostic and therapeutic considerations in clinical primary pulmonary hypertension
Respir Med
(1990) - et al.
Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension
Am J Med
(1984) - et al.
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group
N Engl J Med
(1996) - et al.
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial
Ann Intern Med
(2000)